UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 152

Sortiert nach

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m(2) 24 h or 1.3 mg/m(2) 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Annals of oncology, 2009-11, Vol.20 (11), p.1794

2009

Link zum Volltext

Verfügbarkeit prüfen

Adverse event profile by folate receptor status for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

Gynecologic oncology, 2014-06, Vol.133, p.178-178

2014

Link zum Volltext

Verfügbarkeit prüfen

CA-125 as a response marker for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: The PRECEDENT trial

Gynecologic oncology, 2014-06, Vol.133, p.177-178

2014

Link zum Volltext

Verfügbarkeit prüfen

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

International journal of gynecological cancer, 2017-05, Vol.27 (4), p.832-837

2017

Link zum Volltext

Verfügbarkeit prüfen

8029 POSTER Health-Related Quality of Life (HRQoL)/Patient Reported Outcomes (PRO) of Patients (pts) With Partially Platinum Sensitive (PPS) Recurrent Ovarian Cancer (ROC) Treated in a Randomized Phase III Trial of Trabectedin and Pegylated Liposomal Doxorubicin (PLD) Vs PLD Alone (OVA-301) – an Exploratory Analysis

European journal of cancer (1990), 2011, Vol.47, p.S536-S536

2011

Link zum Volltext

Verfügbarkeit prüfen

8004 ORAL Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment – Pooled Analysis of Phase II Trials

European journal of cancer (1990), 2011, Vol.47, p.S528-S529

2011

Link zum Volltext

Verfügbarkeit prüfen

I043 THE ROLE OF SURGERY IN RELAPSED OVARIAN CANCER

International journal of gynecology and obstetrics, 2012-10, Vol.119 (S3), p.S171-S171

Bidziński, M.

2012

Link zum Volltext

Verfügbarkeit prüfen

EP894 Evaluation of the clinical usefulness of HE4 and CA125 assays in monitoring treatment response of patients with advanced ovarian cancer

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A483-A484

2019

Link zum Volltext

Verfügbarkeit prüfen

EP386 Cervical cancer screening in PHC organization in poland

International journal of gynecological cancer, 2019-11, Vol.29 (Suppl 4), p.A259-A259

2019

Link zum Volltext

Verfügbarkeit prüfen

44TiP ENGOT-ov65/KEYNOTE-B96: Phase III, randomized, double-blind study of pembrolizumab vs placebo + paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer

Annals of oncology, 2022-06, Vol.33, p.S400-S401

2022

Link zum Volltext

Verfügbarkeit prüfen

0279: Evaluation of Prognostic Factors in Borderline Ovarian Tumors

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.680-680

2006

Link zum Volltext

Verfügbarkeit prüfen

0131: Primary Peritoneal Serous Papillary Carcinoma (PSPC)-Clinicopathologic Characteristics

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.638-638

2006

Link zum Volltext

Verfügbarkeit prüfen

000432 COMPARISON OF PRETREATMENT MRI AND PROTON MR SPECTROSCOPY WITH SURGICO-PATHOLOGIC FINDINGS IN PATIENTS TREATED FOR STAGE I AND II INVASIVE CARCINOMA OF THE CERVIX

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.171-171

2005

Link zum Volltext

Verfügbarkeit prüfen

39MO Phase III ENGOT-En9/LEAP-001 study: Lenvatinib + pembrolizumab (LEN/PEMBRO) vs chemotherapy (chemo) as first-line (1L) therapy for advanced or recurrent endometrial cancer

ESMO open, 2024-06, Vol.9, p.103539, Article 103539

2024

Link zum Volltext

Verfügbarkeit prüfen

0239: Prognostic Value of Pretreatment Serum Ca 125 and Cytokine Levels in Patients with Ovarian Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.668-668

2006

Link zum Volltext

Verfügbarkeit prüfen

0512: Clinical Utility of Examining Tumor Markers and Cytokines in Patients with Cervical Adeno- Carcinoma

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.744-744

2006

Link zum Volltext

Verfügbarkeit prüfen

Precedent Subset Analysis: Safety and Disease Control with Vintafolide Monotherapy Following Discontinuation of Pegylated Liposomal Doxorubicin (Pld)

Annals of oncology, 2014-09, Vol.25, p.iv312

2014

Link zum Volltext

Verfügbarkeit prüfen

0290: The Multidetector Computed Tomography (Mdct) in Differentiation of Suspected Ovarian Tumors

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.683-683

2006

Link zum Volltext

Verfügbarkeit prüfen

PROGNOSTIC VALUE OF MMP-2 AND TIMP-2 EXPRESSION IN EARLY STAGE INVASIVE CARCINOMA OF THE CERVIX

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.237-237

2004

Link zum Volltext

Verfügbarkeit prüfen

000453 INTERPRETATION OF RESULTS OF HER2 ASSESSMENT IN OVARIAN EPITHELIAL TUMORS

International journal of gynecological cancer, 2005-09, Vol.15 (Suppl 2), p.176-176

2005

Link zum Volltext

Verfügbarkeit prüfen

THE ASSESSMENT OF HER2 STATUS IN EPITHELIAL OVARIAN TUMOURS

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.197-198

2004

Link zum Volltext

Verfügbarkeit prüfen

EFFECTIVENESS OF SURGERY AND INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED VULVAR CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.208-208

2004

Link zum Volltext

Verfügbarkeit prüfen

CLINICAL EFFECTIVENESS OF SURGERY AND INTERSTITIAL BRACHYTHERAPY HDR IN THE COMBINED TREATMENT OF VULVAR CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.208-208

2004

Link zum Volltext

Verfügbarkeit prüfen

ANALYSIS OF TIME TO PROGRESSION BETWEEN PATIENTS TREATED BECAUSE ENDOMETRIAL CANCER STAGE IIIC

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.226-226

2004

Link zum Volltext

Verfügbarkeit prüfen

0069: The Importance of the Time Factor in Combined Treatment of Endometrial Cancer

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.619-619

2006

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 152

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(124)

Publikationsform

Artikel
(151)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(57)
Animals
(55)
Life Sciences & Biomedicine
(55)
Rats
(52)
Male
(49)
Biological And Medical Sciences
(30)
Rats, Wistar
(30)
Neurosciences
(27)
Neurosciences & Neurology
(27)
Pharmacology & Pharmacy
(26)
Behavioral Sciences
(18)
Fundamental And Applied Biological Sciences. Psychology
(18)
Brain - Metabolism
(16)
Ovarian Cancer
(15)
Hippocampus - Metabolism
(14)
Psychology. Psychoanalysis. Psychiatry
(14)
Brain - Drug Effects
(13)
Medical Sciences
(13)
Hippocampus - Drug Effects
(12)
Psychology. Psychophysiology
(11)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Phase II randomized study of trabectedin given as two different every 3 weeks dose schedules (1.5 mg/m(2) 24 h or 1.3 mg/m(2) 3 h) to patients with relapsed, platinum-sensitive, advanced ovarian cancer

Adverse event profile by folate receptor status for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer

CA-125 as a response marker for vintafolide + pegylated liposomal doxorubicin vs pegylated liposomal doxorubicin alone in platinum-resistant ovarian cancer: The PRECEDENT trial

European Society of Gynaecological Oncology Guidelines for the Management of Patients With Vulvar Cancer

8004 ORAL Safety and Efficacy Outcomes in Heavily and Non-heavily Pretreated Patients With Recurrent Ovarian Cancer (ROC) After Single-agent Trabectedin Treatment – Pooled Analysis of Phase II Trials

I043 THE ROLE OF SURGERY IN RELAPSED OVARIAN CANCER

EP894 Evaluation of the clinical usefulness of HE4 and CA125 assays in monitoring treatment response of patients with advanced ovarian cancer

EP386 Cervical cancer screening in PHC organization in poland

44TiP ENGOT-ov65/KEYNOTE-B96: Phase III, randomized, double-blind study of pembrolizumab vs placebo + paclitaxel with optional bevacizumab for platinum-resistant recurrent ovarian cancer

0279: Evaluation of Prognostic Factors in Borderline Ovarian Tumors

0131: Primary Peritoneal Serous Papillary Carcinoma (PSPC)-Clinicopathologic Characteristics

000432 COMPARISON OF PRETREATMENT MRI AND PROTON MR SPECTROSCOPY WITH SURGICO-PATHOLOGIC FINDINGS IN PATIENTS TREATED FOR STAGE I AND II INVASIVE CARCINOMA OF THE CERVIX

39MO Phase III ENGOT-En9/LEAP-001 study: Lenvatinib + pembrolizumab (LEN/PEMBRO) vs chemotherapy (chemo) as first-line (1L) therapy for advanced or recurrent endometrial cancer

0239: Prognostic Value of Pretreatment Serum Ca 125 and Cytokine Levels in Patients with Ovarian Cancer

0512: Clinical Utility of Examining Tumor Markers and Cytokines in Patients with Cervical Adeno- Carcinoma

Precedent Subset Analysis: Safety and Disease Control with Vintafolide Monotherapy Following Discontinuation of Pegylated Liposomal Doxorubicin (Pld)

0290: The Multidetector Computed Tomography (Mdct) in Differentiation of Suspected Ovarian Tumors

PROGNOSTIC VALUE OF MMP-2 AND TIMP-2 EXPRESSION IN EARLY STAGE INVASIVE CARCINOMA OF THE CERVIX

000453 INTERPRETATION OF RESULTS OF HER2 ASSESSMENT IN OVARIAN EPITHELIAL TUMORS

THE ASSESSMENT OF HER2 STATUS IN EPITHELIAL OVARIAN TUMOURS

EFFECTIVENESS OF SURGERY AND INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF LOCALLY ADVANCED VULVAR CANCER

CLINICAL EFFECTIVENESS OF SURGERY AND INTERSTITIAL BRACHYTHERAPY HDR IN THE COMBINED TREATMENT OF VULVAR CANCER

ANALYSIS OF TIME TO PROGRESSION BETWEEN PATIENTS TREATED BECAUSE ENDOMETRIAL CANCER STAGE IIIC

0069: The Importance of the Time Factor in Combined Treatment of Endometrial Cancer

Aktive Filter

Suchergebnisse filtern